0000950123-20-001647.txt : 20200212 0000950123-20-001647.hdr.sgml : 20200212 20200212172131 ACCESSION NUMBER: 0000950123-20-001647 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200212 DATE AS OF CHANGE: 20200212 EFFECTIVENESS DATE: 20200212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Svennilson Peter CENTRAL INDEX KEY: 0001606074 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16412 FILM NUMBER: 20605556 MAIL ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001606074 XXXXXXXX 12-31-2019 12-31-2019 Svennilson Peter

1700 OWENS STREET SUITE 500 San Francisco CA 94158

13F HOLDINGS REPORT 028-16412 N Peter Svennilson (415) 865-2050 /s/ Peter Svennilson San Francisco CA 02-11-2020 10 7 837452 false 1 28-19198 The Column Group II, LP 2 28-19199 The Column Group II GP, LP 3 28-16413 David Goeddel 4 28-16410 The Column Group, LP 5 28-16411 The Column Group GP, LP 6 Ponoi Capital, LP 7 Ponoi Management, LLC 8 Tim Kutzkey 9 Ponoi Capital II, LP 10 Ponoi II Management, LLC INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F Arcus Biosciences Inc COM 03969F109 35763 3540850 SH OTR 1,2,3,6,7,8 0 3540850 0 Constellation Pharmceticls I COM 210373106 283117 6009702 SH OTR 3,4,5,6,7,8,9,10 0 6009702 0 Gritstone Oncology Inc COM 39868T105 27833 3102934 SH OTR 1,2,3 0 3102934 0 NGM Biopharmaceuticals Inc COM 62921N105 297077 16066907 SH OTR 1,2,3,4,5,6,7,8,9,10 0 16066907 0 NGM Biopharmaceuticals Inc COM 62921N105 6544 353922 SH OTR 3,8 0 353922 0 RAPT Therapeutics Inc COM 75382E109 185737 6727151 SH OTR 1,2,3,6,7,8,9,10 0 6727151 0 RAPT Therapeutics Inc COM 75382E109 1381 50000 SH OTR 3 0 50000 0